A detailed history of Cibc Private Wealth Group, LLC transactions in Biolife Solutions Inc stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 54,068 shares of BLFS stock, worth $1.44 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
54,068
Previous 60,818 11.1%
Holding current value
$1.44 Million
Previous $1.13 Million 2.66%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$15.14 - $22.99 $102,195 - $155,182
-6,750 Reduced 11.1%
54,068 $1.16 Million
Q4 2023

Feb 13, 2024

SELL
$8.99 - $16.86 $184,295 - $345,630
-20,500 Reduced 25.21%
60,818 $988,000
Q3 2023

Nov 13, 2023

BUY
$10.81 - $22.96 $63,573 - $135,027
5,881 Added 7.8%
81,318 $1.12 Million
Q2 2023

Nov 21, 2023

SELL
$17.19 - $24.34 $101,094 - $143,143
-5,881 Reduced 7.23%
75,437 $1.67 Million
Q2 2023

Aug 10, 2023

SELL
$17.19 - $24.34 $171,900 - $243,400
-10,000 Reduced 11.7%
75,437 $1.67 Million
Q1 2023

Nov 21, 2023

BUY
$17.67 - $26.07 $72,782 - $107,382
4,119 Added 5.07%
85,437 $1.86 Million
Q1 2023

May 11, 2023

SELL
$17.67 - $26.07 $176,700 - $260,700
-10,000 Reduced 10.48%
85,437 $1.86 Million
Q4 2022

Jun 01, 2023

BUY
$16.95 - $25.07 $169,500 - $250,700
10,000 Added 11.7%
95,437 $1.74 Million
Q4 2022

Feb 13, 2023

SELL
$16.95 - $25.07 $84,750 - $125,350
-5,000 Reduced 4.98%
95,437 $1.74 Million
Q3 2022

Nov 14, 2022

SELL
$14.64 - $26.7 $288,408 - $525,990
-19,700 Reduced 16.4%
100,437 $2.29 Million
Q1 2022

May 16, 2022

SELL
$20.81 - $37.29 $832 - $1,491
-40 Reduced 0.03%
120,137 $2.73 Million
Q4 2021

Feb 08, 2022

SELL
$32.99 - $58.55 $280,415 - $497,675
-8,500 Reduced 6.61%
120,177 $4.48 Million
Q3 2021

Nov 12, 2021

BUY
$42.03 - $60.5 $5.41 Million - $7.78 Million
128,677 New
128,677 $5.45 Million

Others Institutions Holding BLFS

About BIOLIFE SOLUTIONS INC


  • Ticker BLFS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 42,684,400
  • Market Cap $1.14B
  • Description
  • BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...
More about BLFS
Track This Portfolio

Track Cibc Private Wealth Group, LLC Portfolio

Follow Cibc Private Wealth Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Private Wealth Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Private Wealth Group, LLC with notifications on news.